896 related articles for article (PubMed ID: 16085959)
21. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
[TBL] [Abstract][Full Text] [Related]
22. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
Wang J; Chen H; Shi H; Zhang X; Shao Y; Hang B; Xu Z; Rong X; Chu M; Qiu H
Pediatr Rheumatol Online J; 2020 Jun; 18(1):48. PubMed ID: 32527316
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors of medium-giant coronary artery aneurysms in Kawasaki disease.
Jiang S; Li M; Xu K; Xie Y; Liang P; Liu C; Su Q; Li B
Pediatr Res; 2024 Jan; 95(1):267-274. PubMed ID: 37670043
[TBL] [Abstract][Full Text] [Related]
24. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
25. [Cardiac involvement in Kawasaki disease. Our experience].
Sciacca P; Falsaperla R; Barone P; Tornambene G; Mattia C; Marletta M; Betta P; Distefano G
Minerva Pediatr; 2001 Apr; 53(2):87-93. PubMed ID: 11404729
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
[TBL] [Abstract][Full Text] [Related]
28. Infections and Kawasaki disease: implications for coronary artery outcome.
Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
Millar K; Manlhiot C; Yeung RS; Somji Z; McCrindle BW
Int J Cardiol; 2012 Jan; 154(1):9-13. PubMed ID: 20851480
[TBL] [Abstract][Full Text] [Related]
30. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
[TBL] [Abstract][Full Text] [Related]
31. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
Kossiva L; Karanassios E; Papadopoulos G; Karavanaki K
Cardiol Young; 2012 Aug; 22(4):461-5. PubMed ID: 21933460
[TBL] [Abstract][Full Text] [Related]
32. Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?
McCandless RT; Minich LL; Tani LY; Williams RV
Am J Cardiol; 2010 Jun; 105(11):1625-8. PubMed ID: 20494673
[TBL] [Abstract][Full Text] [Related]
33. Dissecting Kawasaki disease: a state-of-the-art review.
Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
[TBL] [Abstract][Full Text] [Related]
34. Cost-effective use of echocardiography in children with Kawasaki disease.
Scott JS; Ettedgui JA; Neches WH
Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
36. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Tang Y; Yan W; Sun L; Xu Q; Ding Y; Lv H
Clin Rheumatol; 2018 Jul; 37(7):1945-1951. PubMed ID: 29330741
[TBL] [Abstract][Full Text] [Related]
37. [Retrospective analysis of infliximab in the treatment of Kawasaki disease].
Xie LP; Zhao L; Chu C; He L; Liang XC; Sun SN; Zhao QM; Wang F; Cao YY; Lin YX; Zeng ZQ; Wu L; Huang GY; Liu F
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):14-19. PubMed ID: 34986617
[No Abstract] [Full Text] [Related]
38. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and mid-term follow-up in infants younger than 3 months with Kawasaki disease in a Chinese population.
Li W; Zhang L; Huang P; Zhang Z
J Paediatr Child Health; 2019 May; 55(5):523-527. PubMed ID: 30246351
[TBL] [Abstract][Full Text] [Related]
40. Multiple giant aneurysms and stenoses of the coronary and systemic arteries in an infant with kawasaki disease at the early stage of convalescent period.
Ekici F; Varan B; Kocabaş A; Erdoğan İ; Eminoğlu S; Aktaş D
Echocardiography; 2014 May; 31(5):E147-50. PubMed ID: 24528198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
